Endomag Sentimag

Endomag has developed an innovative technology, currently focused on breast cancer surgery, to help surgeons locate cancerous tumours. 

The company is using magnetic field technologies as a method for detecting early-stage and often impalpable cancers. With the company’s detection probe instrument, Sentimag, an ultra-sensitive magnetometer that can detect minute quantities of magnetic material, coupled with Endomag’s ‘locating’ or ‘tracing’ products, Magseed or Magtrace, surgeons can be guided with unprecedented accuracy.

Magseed is a magnetisable seed, smaller than a grain of rice, that is inserted into the centre of a tumour to act as a beacon for surgical removal. Magseed is the only localisation device that has received FDA clearance for long-term and soft tissue implantation.

Magtrace is a magnetic fluid containing tiny iron oxide particles designed to mimic the route that spreading cancer cells are most likely to follow and is the only commercialised nanoparticle approved as a medical device.

Endomag’s system has been used successfully in more than 30,000 procedures across 300 hospitals in 30 countries and is the subject of 12 clinical publications.

Endomag Magtrace

Cookie Settings